Anti-Human CD253 PE Conjugated

Product Specifications

Catalogue N°

853.082.010 - 100 tests / 1ml

Target species

Human

Specificity

Recognises the TRAIL, APO2L antigen, a 32 kDa protein

Clone

B-S23

Application

Flow Cytometry

Hybridoma

Myeloma X63/AG.8653 x Balb/c spleen cells

Immunisation

Recombinant human TRAIL

Quantity

100 Tests / 1ml (Discovery Size also available please enquire)

Isotype

Mouse IgG1 Kappa light chain

Format

Phosphate-buffered saline with 5% BSA and 0.09% sodium azide

Workshop

VIII

Storage

Stable at +2-8°C for six months after reconstitution. DO NOT FREEZE.

Working Dilution

Reconstitute with 1 ml deionised water. Use 10μl to label 10⁶ cells or 100 μl of whole blood.

Synonym

APO2L

• References
• Related products

Sodium azide is a poisonous and hazardous substance, handle and dispose of properly

BACKGROUND

TRAIL, TNF-Related Apoptosis-Inducing Ligand (TRAIL), is a member of the tumor necrosis factor (TNF) family, also designated as Apo-2 ligand (Apo-2L) and CD253. TRAIL is a 281-amino acid protein, related most closely to Fas/Apo-1 ligand. It is expressed at cell surface as a transmembrane protein with an extracellular region and a homotrimeric subunit structure and also exists as a soluble form.

TRAIL interacts with several receptors: two pro-apoptotic death receptors DR4 (TRAIL R1) and DR5 (TRAIL R2) and three anti-apoptotic decoy receptors DcR1 (TRAIL R3), DcR2 (TRAIL R4) and osteoprotegrin (OPG). Soluble TRAIL induces apoptosis through these death receptors in many transformed cells (lymphoid as well as non-lymphoid tumor cell lines).

Because of its role in apoptosis and its stable trimer, TRAIL was described as a potential tumor-specific cancer therapeutic.

Version 13 - 09.19

For research use only

For any order, the purchaser acknowledges having read and accepted the terms and conditions described on the Diaclone website.